SOD1 and Parkinson disease: This is particularly interesting given that mutant and wild-type SOD1 pathology in ALS and Parkinson disease exhibit common structural characteristics [29, 85], yet the global expression of human mutant SOD1 aggressively impacts spinal motor neurons, while the global induction of human wild-type SOD1 pathology results in nigral dopamine neuron death.